Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Org 25969

Org 25969

pharmaceutical raw materials
Org 25969 structure

Org 25969 

structure
  • CAS No:

    343306-79-6

  • Formula:

    C72H112O48S8.8Na

  • Chemical Name:

    Org 25969

  • Synonyms:

    γ-Cyclodextrin,6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-,sodium salt (1:8);γ-Cyclodextrin,6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-,octasodium salt;Org 25969;Sugammadex sodium;6-Per-deoxy-6-per-(2-carboxyethyl)thio-γ-cyclodextrin sodium salt;Sugammadex sodium salt;862667-16-1;1202253-72-2

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Sugammadex sodium is a synthetic γ-cyclodextrin derivative, and acts as a new reversal agent for neuromuscular block.


Sugammadex sodium is an organic sodium salt that is the octasodium salt of sugammadex. Used for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery. It has a role as a neuromuscular agent. It contains a sugammadex(8-).|Sugammadex Sodium is the sodium salt form of sugammadex, a biologically inert, selective relaxant binding agent (SRBA) composed of a modified, anionic gamma cyclodextrin derivative containing a hydrophilic exterior and a hydrophobic core, with neuromuscular blocking drug (NMBD) reversal activity. Upon administration, the negatively charged carboxyl-thio-ether groups of sugammadex selectively and reversibly bind to the positively charged quaternary nitrogen of a steroidal NMBD, such as rocuronium and vecuronium, which was administered at an earlier time for anesthetic purposes. The encapsulation of the NMBD by sugammadex blocks its ability to bind to nicotinic receptors in the neuromuscular junction and thereby reverses the NMBD-induced neuromuscular blockade.|A gamma-cyclodextrin that functions as a reversal agent for the neuromuscular blocker ROCURONIUM BROMIDE.

Org 25969 Basic Attributes

2177.974

2176.26000

608-974-4

ERJ6X2MXV7

C78123

V03AB35|V - Various

Characteristics

995

1.275g/cm3 (计算值)

Safety Information

|Warning|H302 (98.11%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 58 companies from 3 notifications to the ECHA C&L Inventory.

Drug Information

Reversal of neuromuscular blockade induced by rocuronium or vecuronium.For the peadiatric population: sugammadex is only recommended for routine reversal of rocuronium-induced blockade in children and adolescents.

6-perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt

Org 25969 Use and Manufacturing

Uses

Reversal agent for neuromuscular blocking drugs.

Human drugs -> Bridion -> EMA Drug Category|All other therapeutic products -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:2178.0
Hydrogen Bond Donor Count:16
Hydrogen Bond Acceptor Count:56
Rotatable Bond Count:32
Exact Mass:2176.2644287
Monoisotopic Mass:2176.2644287
Topological Polar Surface Area:995
Heavy Atom Count:136
Complexity:2790
Defined Atom Stereocenter Count:40
Covalently-Bonded Unit Count:9
Compound Is Canonicalized:Yes

Related Drugs

Registered Holders

  • MANKIND PHARMA LTD

    United States United States
    Active
  • MSN LIFE SCIENCES PRIVATE LTD

    United States United States
    Active
  • HONOUR LAB LTD

    United States United States
    Active

Recommended Suppliers of Org 25969

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.